AMR Centre, Shionogi team up for superbug therapy - PharmaTimes

AMR Centre, Shionogi team up for superbug therapy  PharmaTimes

The AMR Centre has announced a landmark agreement with the Japanese pharma company Shionogi to take forward its anti-virulence program, COT-143.



Comments

Popular posts from this blog

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today